Preparation method of absorbable biological material for plugging pneumothorax ventage
By preparing and applying absorbable biological materials to seal the pneumothorax leak, the operating risks and complications of pneumothorax leak sealing in the prior art are solved, and more efficient healing effects are achieved, reducing the complication risk of patients.
Patent Information
- Application Number
- CN202411153105.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-21
- Publication Date
- 2024-11-29
AI Technical Summary
The prior art has operating risks and complications in pneumothoracic leak closure, especially the risk of displacement and asphyxiation of bronchial occlusion, and the drainage effect is poor, making it difficult to effectively heal the patient's lung puncture leak.
Using an absorbable biological material preparation method, by mixing thrombin, hydrogel, cellulose, turmeric extract, vitamin B powder, fibroblast growth factor and polylactic acid-polycaprolactone and other materials, stirring and heating and extrude to form a film-like biological material for sealing the pneumothorax leak, and performing quality inspection and sterile packaging.
This method provides a safer and more effective means of sealing. The material has high viscosity and automatic ductility, promotes leak healing, reduces the occurrence of complications, and improves the safety and effectiveness of pneumothorax treatment.
Smart Images

Figure CN119034018A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medical equipment, and in particular relates to a method for preparing an absorbable biomaterial for plugging a pneumothorax leak. Background Art
[0002] After lung puncture, pneumothorax will occur, similar to a leaky tire. If the amount of pneumothorax is small, it can generally be absorbed by itself. If it is large, generally 30% requires pneumothorax drainage. For patients with poor lung function such as emphysema and bullae, only a small amount of pneumothorax will be actively drained. Currently, drainage mainly includes closed chest drainage bags and drainage bottles. The drainage effect is not particularly good, but the root cause of pneumothorax is that the leakage of the patient's lung puncture is difficult to heal. After the patient's lung is punctured, the patient's lung is generally blocked with an occluder, but the occluder has operational risks, and the bronchial occluder may be displaced during the operation. The cuff blocks the main trachea and causes suffocation. If a blind probe is used to insert the catheter, it is easy to cause tracheal mucosal damage when adjusting the position. Although the use of fiber bronchoscope can improve the success rate of the catheter and reduce the probability of complications, the operation itself is still risky. The blocking cuff of the bronchial occluder may sometimes penetrate into the surgical lung, which may damage the catheter and cuff during the operation. After the cuff is relaxed, if the accumulated secretions are not cleared in time, it may cause contamination of the healthy lung. It is inconvenient to use and there are safety hazards. In this regard, we proposed a method for preparing absorbable biomaterials for blocking pneumothorax leaks. Summary of the invention
[0003] In view of the deficiencies in the prior art, the present invention provides a method for preparing an absorbable biomaterial for plugging a pneumothorax leak to solve the above technical problems.
[0004] To achieve the above object, the present invention provides the following technical solution: a method for preparing an absorbable biomaterial for plugging a pneumothorax leak, the preparation steps being:
[0005] S1. Prepare the following materials: 10-900 parts of thrombin, 10-1200 parts of hydrogel, 10-560 parts of cellulose, 100-900 parts of polyamino acid, 100-850 parts of turmeric extract, 10-360 parts of vitamin B powder, 10-730 parts of fibroblast growth factor, 10-500 parts of polylactic acid-polycaprolactone and 10-250 parts of polylactic acid;
[0006] S2, washing the outer surface of the hydrogel to remove impurities on the outer surface;
[0007] S3, pouring the hydrogel, cellulose, polyamino acid, turmeric extract, vitamin B powder, polylactic acid-polycaprolactone and polylactic acid into a planetary mixer and stirring for 1 hour;
[0008] S4. After stirring for 45 minutes, add fibroblast growth factor into the planetary mixer and stir;
[0009] S5, heating the mixed material at a temperature of 40° C., extruding the mixed material to form a film, and waiting for cooling and solidification to form a biomaterial;
[0010] S6. Conduct quality inspection on biomaterials, including appearance inspection, active ingredient content inspection and absorbability inspection;
[0011] S7. Aseptically package the tested biological materials.
[0012] Preferably, the specific amounts of materials in step S1 are: 120 parts of thrombin, 800 parts of hydrogel, 230 parts of cellulose, 400 parts of polyamino acid, 130 parts of turmeric extract, 210 parts of vitamin B powder, 550 parts of fibroblast growth factor, 200 parts of polylactic acid-polycaprolactone and 90 parts of polylactic acid.
[0013] Preferably, in step S1, the hydrogel is methacrylated gelatin, the cellulose is one of natural cellulose and artificial cellulose, and the fibroblast growth factor is one of platelet-like fibroblast growth factor, epidermal fibroblast growth factor, fibroblast growth factor and insulin-like fibroblast growth factor, or more than one of them.
[0014] Preferably, the preparation step of the hydrogel in step S1 comprises preparing raw materials, dissolving the prepared materials in deionized water, stirring and heating, allowing the cellulose molecular chains to form a network structure through hydrogen bonds and ionic interactions, and after the cross-linking reaction is completed, pouring the obtained gel solution into a mold to solidify the gel into shape, and using Fourier transform infrared spectroscopy and field emission scanning electron microscopy to characterize and test the prepared hydrogel to evaluate the structure, performance and function, thereby completing the preparation.
[0015] Preferably, the polyamino acid synthesis method in step S1 is prepared by solid phase synthesis, which involves selecting a carrier, introducing a group reactive with a carboxyl group onto the carrier, performing an activation reaction, and performing a coupling reaction, using a deprotection reagent to remove the amino protecting group to release the free amino acid, using a cutting fluid to break the synthesized titanium chain from the carrier, and using mass spectrometry to detect the polyamino acid.
[0016] Preferably, in step S1, the turmeric extract is extracted by alcohol extraction, and the vitamin B powder is prepared by preparing vitamin B1 and vitamin B2, crushing the prepared vitamin B, filtering, filtering out large particles of vitamin B particles, and obtaining vitamin B powder.
[0017] Preferably, in step S2, the washing is performed by pre-immersing the hydrogel in clean water, and then washing the outer surface of the hydrogel with clean water after soaking; in step S3, the rotation speed of the planetary mixer is 140±5r / min, and the power during stirring is 0.37kW. During stirring, the agitator rotates around its own axis and around the central axis at the same time to evenly mix the materials.
[0018] Preferably, in step S5, the heating is performed by a heater for 20 minutes. After the heating is completed, the material is sent to an extruder for extrusion and waits for natural cooling and solidification.
[0019] Preferably, in step S6, the appearance inspection is performed by checking the overall appearance of the biological material to ensure that the product appearance does not contain foreign matter or turbidity, and the prepared material is preliminarily inspected by the naked eye, and then the instrument is used to assist in the inspection and judgment; the active ingredient content is detected by preparing samples, extracting and purifying the samples, adjusting the wavelength of the ultraviolet spectrophotometer to a wavelength suitable for the detection of the target active ingredient, taking an appropriate amount of the purified sample and diluting it to an appropriate concentration, placing it in a colorimetric dish for detection, reading the data, and calculating the OD value of the active ingredient based on the test data, and then deriving its content, comparing the test results with the standard or the known active ingredient content to ensure the accuracy of the test results, and recording the test results in detail.
[0020] Preferably, the absorbability test in step S6 is performed by preparing samples, preparing biomaterial samples into discs, marking each sample, configuring an organic solvent as an adsorption object, adding the sample to the configured solution, and allowing the mixed solution to stand for a period of time to allow the sample to fully absorb the substance in the solution. An electronic balance device is used to measure the change in mass of the solution before and after adsorption, and the adsorption amount of the biomaterial on the substance in the solution is calculated based on the measurement data.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] The present application uses absorbable biomaterials to seal the patient's leakage. The main body of the material is hydrogel, which has high viscosity and is injectable. After the material is injected, it automatically extends into a large circular area to seal the leakage. Anti-inflammatory growth factors are added to promote the healing and growth of the leakage, providing a healthier sealing method and reducing the occurrence of complications in patients. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The figure is a flowchart of the steps for preparing the biomaterial of the present invention. DETAILED DESCRIPTION
[0024] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0025] The present invention provides a technical solution: a method for preparing an absorbable biomaterial for plugging a pneumothorax leak, the preparation steps being:
[0026] S1. Prepare the following materials: 10-900 parts of thrombin, 10-1200 parts of hydrogel, 10-560 parts of cellulose, 100-900 parts of polyamino acid, 100-850 parts of turmeric extract, 10-360 parts of vitamin B powder, 10-730 parts of fibroblast growth factor, 10-500 parts of polylactic acid-polycaprolactone and 10-250 parts of polylactic acid;
[0027] S2, washing the outer surface of the hydrogel to remove impurities on the outer surface;
[0028] S3, pouring the hydrogel, cellulose, polyamino acid, turmeric extract, vitamin B powder, polylactic acid-polycaprolactone and polylactic acid into a planetary mixer and stirring for 1 hour;
[0029] S4. After stirring for 45 minutes, add fibroblast growth factor into the planetary mixer and stir;
[0030] S5, heating the mixed material at a temperature of 40° C., extruding the mixed material to form a film, and waiting for cooling and solidification to form a biomaterial;
[0031] S6. Conduct quality inspection on biomaterials, including appearance inspection, active ingredient content inspection and absorbability inspection;
[0032] S7. Aseptically package the tested biological materials.
[0033] Furthermore, the specific amounts of materials in step S1 are: 120 parts of thrombin, 800 parts of hydrogel, 230 parts of cellulose, 400 parts of polyamino acid, 130 parts of turmeric extract, 210 parts of vitamin B powder, 550 parts of fibroblast growth factor, 200 parts of polylactic acid-polycaprolactone and 90 parts of polylactic acid;
[0034] Cellulose, a high-molecular-weight polysaccharide composed of glucose, is the main component of plant cell walls;
[0035] The main function of thrombin is to convert fibrinogen into fibrin, which is a key step in the blood coagulation process. Fibrin monomers polymerize under the action of thrombin to form water-insoluble cross-linked fibrin polymer clots, thereby achieving the purpose of hemostasis. When blood vessels are damaged, thrombin is activated to convert fibrinogen into fibrin to form thrombi to fill the wound and prevent further blood loss, thereby maintaining the integrity of the blood vessel wall. Thrombin can also stimulate fibroblast proliferation and collagen synthesis, further promoting wound healing.
[0036] Through molecular design and cross-linking technology, polylactic acid-polycaprolactone and polylactic acid can be used to prepare materials with automatic ductility. Polylactic acid is a synthetic biodegradable thermoplastic aliphatic polyester. After use, it can be completely degraded by microorganisms in nature, and finally produces carbon dioxide and water, which does not pollute the environment. It has good biocompatibility. Polylactic acid-polycaprolactone is a blend of polylactic acid and polycaprolactone. Through blending, the deficiencies in their respective properties can be made up and complementary properties can be achieved. After the material is injected, it automatically extends into a large circular area to seal the leak.
[0037] Furthermore, in step S1, the hydrogel is methacrylated gelatin, the cellulose is one of natural cellulose and artificial cellulose, and the fibroblast growth factor is one of platelet-like fibroblast growth factor, epidermal fibroblast growth factor, fibroblast growth factor and insulin-like fibroblast growth factor, or more than one of them.
[0038] Furthermore, in step S1, the preparation step of the hydrogel comprises preparing raw materials, dissolving the prepared materials in deionized water, stirring and heating, allowing the cellulose molecular chains to form a network structure through hydrogen bonds and ionic interactions, and after the cross-linking reaction is completed, pouring the obtained gel solution into a mold to solidify the gel into shape, and using Fourier transform infrared spectroscopy and field emission scanning electron microscopy to characterize and test the prepared hydrogel to evaluate the structure, performance and function, thereby completing the preparation;
[0039] Hydrogel is a gel with water as the dispersion medium. It can swell rapidly and retain a large volume of water in the swollen state without dissolving. Due to the existence of a cross-linked network, hydrogel can swell and retain a large amount of water. The amount of water absorbed is closely related to the degree of cross-linking. The higher the degree of cross-linking, the lower the water absorption. The water content in the hydrogel can be as low as a few percent or as high as 99%.
[0040] Furthermore, in step S1, the polyamino acid synthesis method is prepared by a solid phase synthesis method, in which a carrier is selected, a group reactive with a carboxyl group is introduced into the carrier, an activation reaction is performed, and a coupling reaction is performed, and a deprotection reagent is used to remove the amino protective group to release a free amino acid, and a cutting liquid is used to break the synthesized titanium chain from the carrier, and the polyamino acid is detected by mass spectrometry;
[0041] Polyamino acids have good biocompatibility and can be degraded into small amino acid molecules by enzymes or hydrolysis reactions in the body and absorbed and excreted. Polyamino acids can undergo conformational changes under conditions of pH, light, heat, and redox, providing new ideas for materials to adapt to changes in the biological microenvironment and targeted delivery.
[0042] Furthermore, in step S1, the turmeric extract is extracted by alcohol extraction, and the vitamin B powder is prepared by preparing vitamin B1 and vitamin B2, crushing the prepared vitamin B, filtering, filtering out large particles of vitamin B particles, and obtaining vitamin B powder;
[0043] Turmeric extract mainly contains curcumin as its main component, which has strong antioxidant capacity and is suitable for products that need to improve antioxidant capacity. It contains more turmeric volatile oil and curcumin and other ingredients, which have anti-inflammatory effects and are suitable for products that need to relieve inflammation.
[0044] The alcohol extraction method uses ethanol, methanol or acetone alcohol solvents to extract the fat-soluble active ingredients in turmeric, including curcumin. The alcohol extraction method can more comprehensively extract the active ingredients in turmeric.
[0045] Furthermore, in step S2, the hydrogel is rinsed by pre-immersing it in clean water, and then the outer surface of the hydrogel is rinsed with clean water after soaking; in step S3, the rotation speed of the planetary mixer is 140±5r / min, and the power during stirring is 0.37kW. During stirring, the agitator rotates around its own axis and around the central axis at the same time to evenly mix the materials.
[0046] Furthermore, in step S5, the heating is performed by a heater for 20 minutes. After the heating is completed, the material is sent to an extruder for extrusion and waits for natural cooling and solidification.
[0047] The steps for aseptic packaging are:
[0048] A1. Ensure that the packaging area is clean and tidy, and disinfect the packaging site;
[0049] A2. Prepare the necessary items: sterile cloth, sterile gloves, sterile packaging container, sterile sealing machine, sterile scissors;
[0050] A3. Check sterile materials: ensure that the sterile materials are within the validity period and are not damaged or contaminated;
[0051] A4. Wear sterile equipment: Operators wear sterile gloves, masks and other protective equipment to ensure that they do not come into contact with the outside world during the packaging process;
[0052] A5. Place the items to be packaged in a sterile packaging container, paying attention to the placement and method of the items to avoid contamination;
[0053] A6. Use sterile sealing machines or sterile tapes to seal the packaging containers, ensuring that the seals are tight and without gaps;
[0054] A7. Check packaging quality: Check the quality of the packaged products to ensure that the seal is firm and free of damage or contamination.
[0055] Example 1
[0056] S1. Prepare the following materials: 120 parts of thrombin, 800 parts of hydrogel, 230 parts of cellulose, 400 parts of polyamino acid, 130 parts of turmeric extract, 210 parts of vitamin B powder, 550 parts of fibroblast growth factor, 200 parts of polylactic acid-polycaprolactone and 90 parts of polylactic acid;
[0057] S2, washing the outer surface of the hydrogel to remove impurities on the outer surface;
[0058] S3, pouring the hydrogel, cellulose, polyamino acid, turmeric extract, vitamin B powder, polylactic acid-polycaprolactone and polylactic acid into a planetary mixer and stirring for 1 hour;
[0059] S4. After stirring for 45 minutes, add fibroblast growth factor into the planetary mixer and stir;
[0060] S5, heating the mixed material at a temperature of 40° C., extruding the mixed material to form a film, and waiting for cooling and solidification to form a biomaterial;
[0061] S6. Conduct quality inspection on biomaterials, including appearance inspection, active ingredient content inspection and absorbability inspection;
[0062] S7. Aseptically package the tested biological materials.
[0063] Example 2
[0064] S1. Prepare the following materials: 550 parts of thrombin, 1100 parts of hydrogel, 220 parts of cellulose, 150 parts of polyamino acid, 160 parts of turmeric extract, 250 parts of vitamin B powder, 120 parts of fibroblast growth factor, 120 parts of polylactic acid-polycaprolactone and 80 parts of polylactic acid;
[0065] S2, washing the outer surface of the hydrogel to remove impurities on the outer surface;
[0066] S3, pouring the hydrogel, cellulose, polyamino acid, turmeric extract, vitamin B powder, polylactic acid-polycaprolactone and polylactic acid into a planetary mixer and stirring for 1 hour;
[0067] S4. After stirring for 45 minutes, add fibroblast growth factor into the planetary mixer and stir;
[0068] S5, heating the mixed material at a temperature of 40° C., extruding the mixed material to form a film, and waiting for cooling and solidification to form a biomaterial;
[0069] S6. Conduct quality inspection on biomaterials, including appearance inspection, active ingredient content inspection and absorbability inspection;
[0070] S7. Aseptically package the tested biological materials.
[0071] Table 1 below is a table showing the properties of absorbable biomaterials prepared in different embodiments.
[0072] Group Appearance inspection Active ingredient content Absorbability Example 1 Complete without foreign matter many Good absorbency Example 2 Complete without foreign matter many Good absorbency
[0073] Appearance inspection: Check the overall appearance of the biomaterial to ensure that the product does not contain foreign matter or turbidity. Preliminary inspection of the prepared materials is performed by naked eye, and then auxiliary inspection and judgment is performed by instruments.
[0074] The active ingredient content test is carried out by preparing samples, extracting and purifying the samples, adjusting the wavelength of the UV spectrophotometer to a wavelength suitable for the detection of the target active ingredient, taking an appropriate amount of the purified sample and diluting it to an appropriate concentration, placing it in a cuvette for detection, reading the data, and calculating the OD value of the active ingredient based on the test data, and then deriving its content, comparing the test results with the standard or the known active ingredient content to ensure the accuracy of the test results, and recording the test results in detail;
[0075] The absorbability test is carried out by preparing samples, preparing biomaterial samples into discs, marking each sample, configuring an organic solvent as an adsorption object, adding the sample to the configured solution, and letting the mixed solution stand for a period of time to allow the sample to fully absorb the substance in the solution. An electronic balance device is used to measure the change in mass of the solution before and after adsorption, and based on the measurement data, the amount of adsorption of the substance in the solution by the biomaterial is calculated.
[0076] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.
[0077] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for preparing an absorbable biomaterial for blocking pneumothorax leakage, characterized in that: The preparation steps are: S1. Prepare the following materials: 10-900 parts of thrombin, 10-1200 parts of hydrogel, 10-560 parts of cellulose, 100-900 parts of polyamino acid, 100-850 parts of turmeric extract, 10-360 parts of vitamin B powder, 10-730 parts of fibroblast growth factor, 10-500 parts of polylactic acid-polycaprolactone and 10-250 parts of polylactic acid; S2, washing the outer surface of the hydrogel to remove impurities on the outer surface; S3, pouring the hydrogel, cellulose, polyamino acid, turmeric extract, vitamin B powder, polylactic acid-polycaprolactone and polylactic acid into a planetary mixer and stirring for 1 hour; S4. After stirring for 45 minutes, add fibroblast growth factor into the planetary mixer and stir; S5, heating the mixed material at a temperature of 40° C., extruding the mixed material to form a film, and waiting for cooling and solidification to form a biomaterial; S6. Conduct quality inspection on biomaterials, including appearance inspection, active ingredient content inspection and absorbability inspection; S7. Aseptically package the tested biological materials.
2. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: The specific amounts of materials in step S1 are: 120 parts of thrombin, 800 parts of hydrogel, 230 parts of cellulose, 400 parts of polyamino acid, 130 parts of turmeric extract, 210 parts of vitamin B powder, 550 parts of fibroblast growth factor, 200 parts of polylactic acid-polycaprolactone and 90 parts of polylactic acid.
3. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: In step S1, the hydrogel is methacrylated gelatin, the cellulose is one of natural cellulose and artificial cellulose, and the fibroblast growth factor is one of platelet-like fibroblast growth factor, epidermal fibroblast growth factor, fibroblast growth factor and insulin-like fibroblast growth factor, or more than one of them.
4. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: The preparation step of the hydrogel in step S1 is to prepare raw materials, dissolve the prepared materials in deionized water, stir and heat, and form a network structure of cellulose molecular chains through hydrogen bonds and ionic interactions. After the cross-linking reaction is completed, the obtained gel solution is poured into a mold to solidify the gel. The prepared hydrogel is characterized and tested using Fourier transform infrared spectroscopy and field emission scanning electron microscopy to evaluate the structure, performance and function, and complete the preparation.
5. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: In step S1, the polyamino acid synthesis method is prepared by solid phase synthesis. The solid phase synthesis method selects a carrier, introduces a group reactive with a carboxyl group onto the carrier, performs an activation reaction, and performs a coupling reaction. The amino protecting group is removed using a deprotection reagent to release free amino acids. The synthesized titanium chain is broken off from the carrier using a cutting fluid, and the polyamino acid is detected using mass spectrometry.
6. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: In step S1, the turmeric extract is extracted by alcohol extraction, and the vitamin B powder is prepared by preparing vitamin B1 and vitamin B2, crushing the prepared vitamin B, filtering, filtering out large particles of vitamin B particles, and obtaining vitamin B powder.
7. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: In step S2, the hydrogel is rinsed by soaking it in clean water in advance, and then the outer surface of the hydrogel is rinsed with clean water after soaking; in step S3, the rotation speed of the planetary mixer is 140±5r / min, and the power during stirring is 0.37kW. During stirring, the agitator rotates around its own axis and around the central axis at the same time to evenly mix the materials.
8. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: In step S5, the heating is performed by a heater for 20 minutes. After the heating is completed, the material is sent to an extruder for extrusion, and then waited for natural cooling and solidification.
9. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: In step S6, the appearance inspection is performed by checking the overall appearance of the biological material to ensure that the product appearance does not contain foreign matter or turbidity. The prepared material is initially inspected by the naked eye, and then the instrument is used to assist in the inspection and judgment; The active ingredient content is tested by preparing samples, extracting and purifying them, adjusting the wavelength of the UV spectrophotometer to a wavelength suitable for the detection of the target active ingredient, taking an appropriate amount of purified sample and diluting it to an appropriate concentration, placing it in a cuvette for testing, reading the data, and calculating the OD value of the active ingredient based on the test data, and then deriving its content. The test results are compared with the standard or known active ingredient content to ensure the accuracy of the test results and record the test results in detail.
10. The method for preparing an absorbable biomaterial for blocking pneumothorax leakage according to claim 1, characterized in that: The absorbability test in step S6 is carried out by preparing samples, preparing biomaterial samples into discs, marking each sample, configuring an organic solvent as an adsorption object, adding the sample to the configured solution, and allowing the mixed solution to stand for a period of time to allow the sample to fully absorb the substance in the solution. An electronic balance device is used to measure the change in mass of the solution before and after adsorption, and the adsorption amount of the biomaterial on the substance in the solution is calculated based on the measurement data.
